Genetic landscape of congenital insensitivity to pain and hereditary sensory and autonomic neuropathies
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
MR/W002388/1
Medical Research Council - United Kingdom
MR/T020113/1
Medical Research Council - United Kingdom
Swiss National Science Foundation - Switzerland
MR/W002426/1
Medical Research Council - United Kingdom
21950
Versus Arthritis - United Kingdom
I 4699
Austrian Science Fund FWF - Austria
MC_PC_21048
Medical Research Council - United Kingdom
MR/R011737/1
Medical Research Council - United Kingdom
MR/W002388/1
Versus Arthritis - United Kingdom
200183/Z/15/Z
Wellcome Trust - United Kingdom
Wellcome Trust - United Kingdom
PubMed
37769650
PubMed Central
PMC10689924
DOI
10.1093/brain/awad328
PII: 7285774
Knihovny.cz E-zdroje
- Klíčová slova
- CIP, HSAN, HSN, genetics, neuropathies, pain,
- MeSH
- dědičné senzorické a autonomní neuropatie * genetika MeSH
- kanálopatie MeSH
- kongenitální analgezie * genetika MeSH
- lidé MeSH
- mutace genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Congenital insensitivity to pain (CIP) and hereditary sensory and autonomic neuropathies (HSAN) are clinically and genetically heterogeneous disorders exclusively or predominantly affecting the sensory and autonomic neurons. Due to the rarity of the diseases and findings based mainly on single case reports or small case series, knowledge about these disorders is limited. Here, we describe the molecular workup of a large international cohort of CIP/HSAN patients including patients from normally under-represented countries. We identify 80 previously unreported pathogenic or likely pathogenic variants in a total of 73 families in the >20 known CIP/HSAN-associated genes. The data expand the spectrum of disease-relevant alterations in CIP/HSAN, including novel variants in previously rarely recognized entities such as ATL3-, FLVCR1- and NGF-associated neuropathies and previously under-recognized mutation types such as larger deletions. In silico predictions, heterologous expression studies, segregation analyses and metabolic tests helped to overcome limitations of current variant classification schemes that often fail to categorize a variant as disease-related or benign. The study sheds light on the genetic causes and disease-relevant changes within individual genes in CIP/HSAN. This is becoming increasingly important with emerging clinical trials investigating subtype or gene-specific treatment strategies.
Center for Human Genetics Genetikum® 89231 Neu Ulm Germany
Centre for Medical Genetics Universitair Ziekenhuis Brussel 1090 Jette Brussels Belgium
Davis and Davis Children's Hospital University of California Sacramento CA 95817 USA
Department of Genetics Hospital Infantil Doutor Juvêncio Mattos São Luis Maranhão 65015 460 Brazil
Department of Medical Genetics University Hospital Brno 625 00 Brno Czechia
Department of Neurology Medical Faculty of the RWTH Aachen University 52074 Aachen Germany
Department of Neurology University of Iowa Carver College of Medicine Iowa City IA 52242 USA
Department of Neuromuscular Diseases UCL Queen Square Institute of Neurology London WC1N 3BG UK
Department of Orthopedics and Trauma Surgery Medical University of Vienna 1090 Vienna Austria
Department of Pediatrics Government Medical College Kozhikode Kerala 673 008 India
Department of Pedodontics Faculty of Dentistry Dicle University 21200 Diyarbakir Turkey
Genetics Department Sorbonne Université Paris Brain Institute APHP INSERM CNRS 75013 Paris France
Genomics Group Institute of Biomedical and Genetic Engineering Islamabad 44000 Pakistan
INSERM MMG U 1251 Marseille France Aix Marseille Univ 13385 Marseille France
Institute for Paramedical Sciences Khyber Medical University Peshawar KPK 25100 Pakistan
Institute of Human Genetics School of Medicine Technical University of Munich 81675 Munich Germany
Institute of Human Genetics University Hospital Jena 07747 Jena Germany
Institute of Medical Genetics and Applied Genomics University of Tübingen 72076 Tübingen Germany
Institute of Neurophysiology Medical Faculty Uniklinik RWTH Aachen University 52074 Aachen Germany
MVZ Humangenetik Bremen Limbach Genetics 28209 Bremen Germany
Neurologie Praxis für Neurologie und Schlafmedizin 53359 Rheinbach Germany
Nuffield Department of Clinical Neuroscience University of Oxford Oxford OX3 9DU UK
Pediatría Clínica Premium 29601 Marbella Spain
Pediatric Neurology and Neurodevelopment Medanta The Medicity Gurgaon Haryana 122 001 India
Pediatric Neurology Children's Hospital of the King's Daughters in Norfolk Norfolk VA 23507 USA
Zobrazit více v PubMed
Cox JJ, Reimann F, Nicholas AK, et al. . An SCN9A channelopathy causes congenital inability to experience pain. Nature. 2006;444:894–898. PubMed PMC
Leipold E, Liebmann L, Korenke GC, et al. . A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat Genet. 2013;45:1399–1404. PubMed
Dawkins JL, Hulme DJ, Brahmbhatt SB, Auer-Grumbach M, Nicholson GA. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet. 2001;27:309–312. PubMed
Rotthier A, Auer-Grumbach M, Janssens K, et al. . Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I. Am J Hum Genet. 2010;87:513–522. PubMed PMC
Guelly C, Zhu PP, Leonardis L, et al. . Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I. Am J Hum Genet. 2011;88:99–105. PubMed PMC
Kornak U, Mademan I, Schinke M, et al. . Sensory neuropathy with bone destruction due to a mutation in the membrane-shaping atlastin GTPase 3. Brain. 2014;137(Pt 3):683–692. PubMed
Kurth I, Pamminger T, Hennings JC, et al. . Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy. Nat Genet. 2009;41:1179–1181. PubMed
Rivière JB, Ramalingam S, Lavastre V, et al. . KIF1A, An axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am J Hum Genet. 2011;89:219–230. PubMed PMC
Verhoeven K, De Jonghe P, Coen K, et al. . Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet. 2003;72:722–727. PubMed PMC
Einarsdottir E, Carlsson A, Minde J, et al. . A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet. 2004;13:799–805. PubMed
Indo Y, Tsuruta M, Hayashida Y, et al. . Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat Genet. 1996;13:485–488. PubMed
Baets J, Duan X, Wu Y, et al. . Defects of mutant DNMT1 are linked to a spectrum of neurological disorders. Brain. 2015;138(Pt 4):845–861. PubMed PMC
Edvardson S, Cinnamon Y, Jalas C, et al. . Hereditary sensory autonomic neuropathy caused by a mutation in dystonin. Ann Neurol. 2012;71:569–572. PubMed
Palma JA, Yadav R, Gao D, Norcliffe-Kaufmann L, Slaugenhaupt S, Kaufmann H. Expanding the genotypic spectrum of congenital sensory and autonomic neuropathies using whole-exome sequencing. Neurol Genet. 2021;7:e568. PubMed PMC
Yuan JH, Higuchi Y, Ando M, et al. . Multi-type RFC1 repeat expansions as the most common cause of hereditary sensory and autonomic neuropathy. Front Neurol. 2022;13:986504. PubMed PMC
Garofalo K, Penno A, Schmidt BP, et al. . Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. J Clin Invest. 2011;121:4735–4745. PubMed PMC
Fridman V, Suriyanarayanan S, Novak P, et al. . Randomized trial of l-serine in patients with hereditary sensory and autonomic neuropathy type 1. Neurology. 2019;92:e359–e370. PubMed PMC
Auranen M, Toppila J, Suriyanarayanan S, et al. . Clinical and metabolic consequences of L-serine supplementation in hereditary sensory and autonomic neuropathy type 1C. Cold Spring Harb Mol Case Stud. 2017;3:a002212. PubMed PMC
Richards S, Aziz N, Bale S, et al. . Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405–424. PubMed PMC
Carvalho OP, Thornton GK, Hertecant J, et al. . A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy. J Med Genet. 2011;48:131–135. PubMed PMC
Shaikh SS, Nahorski MS, Woods CG. A third HSAN5 mutation disrupts the nerve growth factor furin cleavage site. Mol Pain. 2018;14:1744806918809223. PubMed PMC
Fischer D, Schabhuttl M, Wieland T, Windhager R, Strom TM, Auer-Grumbach M. A novel missense mutation confirms ATL3 as a gene for hereditary sensory neuropathy type 1. Brain. 2014;137(Pt 7):e286. PubMed
Mohammadi S, Jafari Khamirani H, Baneshi M, et al. . A novel nonsense variant in the ATL3 gene is associated with disturbed pain sensitivity, numbness of distal limbs and muscle weakness. Ann Hum Genet. 2023;87:147–157. PubMed
Rajadhyaksha AM, Elemento O, Puffenberger EG, et al. . Mutations in FLVCR1 cause posterior column ataxia and retinitis pigmentosa. Am J Hum Genet. 2010;87:643–654. PubMed PMC
Chiabrando D, Castori M, di Rocco M, et al. . Mutations in the heme exporter FLVCR1 cause sensory neurodegeneration with loss of pain perception. PLoS Genet. 2016;12:e1006461. PubMed PMC
Castori M, Morlino S, Ungelenk M, et al. . Posterior column ataxia with retinitis pigmentosa coexisting with sensory-autonomic neuropathy and leukemia due to the homozygous p.Pro221Ser FLVCR1 mutation. Am J Med Genet B Neuropsychiatr Genet. 2017;174:732–739. PubMed
Bertino F, Firestone K, Bellacchio E, et al. . Heme and sensory neuropathy: Insights from novel mutations in the heme exporter feline leukemia virus subgroup C receptor 1. Pain. 2019;160:2766–2775. PubMed
Li L, Jia C, Tang Y, Kong Y, Xia Y, Ma L. Novel gross deletion mutations in NTRK1 gene associated with congenital insensitivity to pain with anhidrosis. Front Pediatr. 2021;9:638190. PubMed PMC
Kraft F, Kurth I. Long-read sequencing to understand genome biology and cell function. Int J Biochem Cell Biol. 2020;126:105799. PubMed
Shekarabi M, Girard N, Riviere JB, et al. . Mutations in the nervous system–specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II. J Clin Invest. 2008;118:2496–2505. PubMed PMC